6 research outputs found

    Early prediction of response to cetuximab and radiotherapy by FDG-PET/CT for the treatment of a locoregionally advanced squamous cell carcinoma of the hypopharynx

    No full text
    Cetuximab (CTX) is used for the concurrent treatment with radiotherapy (RT) in squamous cell carcinoma of head and neck (HNSCC). There are no reliable clinical predictive markers of effectiveness of CTX at yet. We describe the clinical case of patient who received a CTX/RT to cure locoregionally advanced hypopharyngeal SCC. 2-Deoxy-2-[18F]fluoro-d-glucose positron emission tomography and computed tomography (18FDG-PET/CT) was performed before the treatment and repeated 10 days after CTX induction dose. A repeated 18FDG-PET/CT scan showed dramatic decrease of metabolic parameters. Patient had a complete response after treatment and is still alive and cured after 5 years

    Acute radiation dermatitis evaluation with reflectance confocal microscopy: a prospective study /

    No full text
    BACKGROUND: During radiotherapy (RT), most breast cancer patients experience ionizing radiation (IR)-induced skin injury-acute radiation dermatitis (ARD). The severity of ARD is determined by a physician according to CTCAE or RTOG scales, which are subjective. Reflectance confocal microscopy (RCM) is a noninvasive skin imaging technique offering cellular resolution. Digital dermoscopy (DD) performed in conjugation with RCM can provide more information regarding skin toxicity. The purpose of this study is to create an RCM and DD features-based ARD assessment scale, to assess the association with CTCAE scale and possible predictive value. METHODS: One hundred and three breast cancer patients during RT were recruited; every week, clinical symptoms of ARD (CTCAE scale) were evaluated and RCM, together with digital dermoscopy (DD), was performed. RESULTS: According to RCM; after 2 RT weeks, exocytosis and/or spongiosis were present in 94% of patients; after 3 weeks, mild contrast cells (MMCs) were detected in 45%; disarrayed epidermis (DE) was present in 66% of patients after 4 weeks and in 93% after 5 weeks; abnormal dermal papillae (ADP) were present in 68% of patients after 5 weeks. The coefficients of RCM features (RCMcoef) alone and together with dermoscopically determined erythema (RCM-ERYcoef) were significantly associated with ARD severity grade. RCMcoef is a significant predictive factor for the clinical manifestation of ARD. CONCLUSIONS: RCM features of irradiated skin appear earlier than clinical symptoms, have a characteristic course, and allow the severity of ARD to be predicted

    Individual radiosensitivity as a risk factor for the radiation-induced acute radiodermatitis

    No full text
    Background: Up to 95% of irradiated patients suffer from ionizing radiation (IR) induced early skin reaction, acute radiation dermatitis (ARD). Some experts think that additional skin hydra-tion can reduce acute skin reactions. Individual radiosensitivity (IRS) determined from lymphocytes may help to predict acute radiation toxicity. The purpose of this study is to evaluate the clinical manifestation of ARD in different skincare groups during whole breast radiotherapy depending on IRS and other risk factors. Methods: A total of 108 early-stage breast cancer patients were randomized into best supportive care (BSC) and additional skincare (ASC) groups. IRS was evaluated using a G2 assay modified with caffeine-induced G2 checkpoint arrest. All patients received a 50 Gy dose to the breast planning target volume (PTV). Clinical assessment of ARD symptoms according to the CTCAE grading scale was performed once a week. Results: IRS was successfully determined for 91 out of 108 patients. A total of 10 patients (11%) had normal IRS, 47 patients (52%) were categorized as radiosensitive, and 34 (37%) as highly radiosensitive. There was no significant difference in the manifestation of ARD between patient groups by skincare or IRS. According to logistic regression, patients with bigger breasts were prone to more severe ARD (p = 0.002). Conclusions: The additional skincare did not improve skin condition during RT. A total of 89% of patients had increased radiosensitivity. IRS determined before RT did not show the predictive value for the manifestation of ARD. Logistic regression revealed that breast volume was the most significant risk factor for the manifestation of ARD

    Effects of Pre- And Postanthesis Applications of Demethylation Inhibitor Fungicides on Fusarium Head Blight and Deoxynivalenol in Spring and Winter Wheat

    No full text
    Anthesis is generally recommended as the optimum growth stage for ap- and PA resulted in the highest Ģ„C values for IND, 52.2 and 51.5%, respecplying a foliar fungicide to manage Fusarium head blight (FHB) and the tively, compared with 45.9% for CL, 41.3% for PL, and less than 33% for Fusarium-associated toxin deoxynivalenol (DON) in wheat. However, CE and PE. Anthesis and postanthesis treatments reduced mean IND by because it is not always possible to treat fields at anthesis, studies were 14.9 to 29.7% relative to preanthesis treatments. The estimated effect size conducted to evaluate pre- and postanthesis treatment options for managwas also statistically significant for comparisons between CA and CL and ing FHB and DON in spring and winter wheat. Network meta-analytical PA and PL; CA reduced IND by 11.7% relative to CL, whereas PA remodels were fitted to data from 19 years of fungicide trials, and log reduced the disease by 17.4% relative to PL. Differences in efficacy against sponse ratio (L) and approximate percent control (CĢ…) relative to a nontreated IND between pairs of prothioconazole + tebuconazole and metconazole check were estimated as measures of the effects of six treatments on FHB treatments applied at the same timing (CE versus PE, CA versus PA, and index (IND: mean percentage of diseased spikelets per spike) and DON. CL versus PL) were not statistically significant. However, CA and CL The evaluated treatments consisted of either Caramba (metconazole) apoutperformed PA and PL by 7 and 12.8%, respectively, in terms of effiplied early (at heading [CE]), at anthesis (CA), or late (5 to 7 days after cacy against DON. All application programs had comparable efficacy anthesis; CL), or Prosaro (prothioconazole + tebuconazole) applied at the against IND between spring and winter wheat types, but efficacy against same three times and referred to as PE, PA, and PL, respectively. All DON was 10 to 16% greater for spring than winter wheat for applications treatments reduced mean IND and DON relative to the nontreated check, made at or after anthesis. All programs led to an increase in mean grain but the magnitude of the effect varied with timing and wheat type. CA yield and test weight relative to the nontreated check

    Soybean yield loss estimates due to diseases in the United States and Ontario, Canada, from 2010 to 2014

    No full text
    Annual decreases in soybean (Glycine max L. Merrill) yield caused by diseases were estimated by surveying university-affiliated plant pathologists in 28 soybean-producing states in theUnitedStates and in Ontario, Canada, from 2010 through 2014. Estimated yield losses from each disease varied greatly by state or province and year. Over the duration of this survey, soybean cyst nematode (SCN) (Heterodera glycines Ichinohe) was estimated to have caused more than twice as much yield loss than any other disease. Seedling diseases (caused by various pathogens), charcoal rot (caused by Macrophomina phaseolina (Tassi) Goid), and sudden death syndrome (SDS) (caused by Fusarium virguliforme O\u27Donnell & T. Aoki) caused the next greatest estimated yield losses, in descending order. The estimated mean economic loss due to all soybean diseases, averaged across U.S. states and Ontario from 2010 to 2014, was $60.66 USD per acre. Results from this survey will provide scientists, breeders, governments, and educators with soybean yield-loss estimates to help inform and prioritize research, policy, and educational efforts in soybean pathology and disease management
    corecore